1. Home
  2. PFS vs AMRX Comparison

PFS vs AMRX Comparison

Compare PFS & AMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PFS
  • AMRX
  • Stock Information
  • Founded
  • PFS 1839
  • AMRX 2002
  • Country
  • PFS United States
  • AMRX United States
  • Employees
  • PFS N/A
  • AMRX N/A
  • Industry
  • PFS Savings Institutions
  • AMRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • PFS Finance
  • AMRX Health Care
  • Exchange
  • PFS Nasdaq
  • AMRX Nasdaq
  • Market Cap
  • PFS 2.4B
  • AMRX 2.5B
  • IPO Year
  • PFS N/A
  • AMRX N/A
  • Fundamental
  • Price
  • PFS $18.22
  • AMRX $8.13
  • Analyst Decision
  • PFS Strong Buy
  • AMRX Strong Buy
  • Analyst Count
  • PFS 5
  • AMRX 4
  • Target Price
  • PFS $23.00
  • AMRX $11.50
  • AVG Volume (30 Days)
  • PFS 636.8K
  • AMRX 1.2M
  • Earning Date
  • PFS 07-24-2025
  • AMRX 08-05-2025
  • Dividend Yield
  • PFS 5.28%
  • AMRX N/A
  • EPS Growth
  • PFS 89.58
  • AMRX N/A
  • EPS
  • PFS 1.77
  • AMRX 0.01
  • Revenue
  • PFS $823,468,000.00
  • AMRX $2,852,914,000.00
  • Revenue This Year
  • PFS $29.83
  • AMRX $9.92
  • Revenue Next Year
  • PFS $11.09
  • AMRX $7.39
  • P/E Ratio
  • PFS $10.30
  • AMRX $749.38
  • Revenue Growth
  • PFS 92.62
  • AMRX 9.81
  • 52 Week Low
  • PFS $14.34
  • AMRX $6.50
  • 52 Week High
  • PFS $22.24
  • AMRX $9.48
  • Technical
  • Relative Strength Index (RSI)
  • PFS 49.82
  • AMRX 53.32
  • Support Level
  • PFS $17.61
  • AMRX $7.67
  • Resistance Level
  • PFS $19.48
  • AMRX $8.24
  • Average True Range (ATR)
  • PFS 0.46
  • AMRX 0.21
  • MACD
  • PFS -0.12
  • AMRX -0.03
  • Stochastic Oscillator
  • PFS 32.62
  • AMRX 51.67

About PFS Provident Financial Services Inc

Provident Financial Services Inc is the holding company for The Provident Bank, a community-oriented bank. The Company's operations are solely in the financial services industry and include providing traditional banking and other financial services to its customers. The Company operates in the geographical regions of northern and central New Jersey, Queens and Nassau Counties in New York and eastern Pennsylvania. The Company has a single reporting segment for financial reporting purposes. The majority of the revenue-generating activities that are components of non-interest income are These revenue streams can generally be classified into three broad categories: wealth management revenue, insurance agency income, and banking service charges and other fees.

About AMRX Amneal Pharmaceuticals Inc.

Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE - It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.

Share on Social Networks: